Tuesday, September 13, 2011

Mirus Bio Files Lawsuit Alleging that Roche’s FuGENE 6 Transfection Reagent Infringes Patent

On September 12, 2011, Mirus Bio sued Fugent, LLC for allegedly infringing its patent entitled "Process of Transfecting a Cell with a Polynucleotide Mixed with an Amphipathic Compound and a DNA-Binding Protein" (U.S. Patent No. 5,744,335). The patent issued in 1998. Claim 1 of the patent recites:

A process of transfecting a polynucleotide into a cell comprising: associating a selected cell with an amphipathic compound, an effective amount of a polynucleotide-binding protein, the polynucleotide-binding protein is selected from the group consisting of histone and histone with a nuclear localizing signal, and a selected polynucleotide, in solution, wherein encapsulation of the polynucleotide by the amphipathic compound is not required for transfection.

Both companies are located in Madison Wisconsin.

The complaint alleges that Fugent infringes the patent, both directly and indirectly (i.e., by inducing its customers to infringe the patent, and/or by contributing to the infringing actions of its customers) by making, using, selling and offering to sell the transfection reagent known as FuGene 6.

FuGene 6 is a Roche product, and appears in the Roche Applied Science catalog. I'm not sure what the relationship is between Fugent and Roche, nor why Roche was not named in the lawsuit.

If you go to Mirus Bio website homepage, this is what you will see:

FuGENE® 6 Supply Problems?
Transfect with TransIT®-LT1
Achieve Comparable Performance
"TransIT-LT1 (MirusBio) has the same performance as FuGENE® 6 (Roche) in our comparison tests."
-The RNAi Consortium (TRC), Broad Institute of MIT and Harvard

Perhaps they are referring to the lawsuit when they suggest people will be having supply problems with FuGENE 6, and might need to switch to the Mirus Bio product TransIT-LT1.

Thanks to Docket Report from Docket Navigator for making me aware of the complaint.

12 comments:

hat said...

roche isn't named in the suit because they own a large part of mirus.

SEO Services said...

Hello, this is a seriouslyoutstanding submit. In theory I'd liketo compose like this too - taking time and real energy to create a great article... but what can I say.!. I procrastinate alot and never appear to acquire something done. Thank You

Android Game Development said...

Pretty impressed by the caliber of intelligence on the webpage. There are a bunch of great resources here. I know I will check out this place often. Web Application Development

Anonymous said...

Hi, Professor Holman,
I always appreciate your thoughtful posts (too bad it looks like bots can get past the security, but not a big deal of course). I wanted to run an idea up the flagpole--am thinking about claims to a method of treatment but am caught between Bilski/Classen and multiple actor considerations. What do you think about trying a "system" claim for a method of treatment, to follow the lead of Centillion v Qwest--so "a system for obtaining treatment for a disease or disorder, comprising a means for obtaining a diagnosis (i.e., a visit to a doctor), a means for treating the disease (i.e., the specific therapy), wherein treatment is obtained" or something along those lines. Then the "system " is put in operation by the patient, as in Centillion. On the other hand, it's probably too much of a stretch to try to fit a method into a system format and might be seen as gaming. I would be interested to hear your thoughts.

Anonymous said...

now promega is selling fugene 6 and theres even a comparison data btw fugene 6 and transit-lt1 performance. arent they the same thing?

Great Penny Stock Investments said...

What about buy and hold not forever but it could be for some time. Their are stocks like petsmart that once traded at 2 dollars a share 11 years ago now the stocks almost fifty. Also pricesmart traded at about 7 or 8 dollars a share about seven or eight ago now its almost around 70 dollars. Their are many other examples Apple computer traded ar only 5 dollars a share in 1998 now its over 400. These stocks are being held quite a long time generally speaking I would say four to six years would be about right as far as buy and hold go. I have a website where I have been following stocks under five dollars. I generally hold my stocks anywhere form 2 to 6 years.

internet marketing belgium said...

a very nice and a fun to read post

hat said...

http://www.businesswire.com/news/home/20120117005164/en the suit is dismissed with prejudice

Leona said...

Your blogs and information attracts me to come back again n again.
yaz attorney

Zara said...

Shazee ka hn

Unknown said...

Never found such informatory contents.

Bankruptcy Lawyer Los Angeles

Ali Gibson said...

asphalt xtreme mod apk jurassic survival mod apk dragon mania legends mod apk